1,516 articles
Michael Rosenblatt
Michael Rosenblatt is an American endocrinologist known for mapping parathyroid hormone's structure and developing PTH 7-34, the first peptide hormone antagonist shown to block hormone action in living animals.
Michael Rutledge DeBaun
Michael Rutledge DeBaun is an American pediatric hematologist at Vanderbilt University School of Medicine, elected to the National Academy of Medicine in 2009 for changing stroke prevention in sickle cell disease.
Michael S. Brown
Michael S. Brown, born 1941, is an American molecular geneticist who co-discovered the LDL receptor with Joseph Goldstein, earning the 1985 Nobel Prize in Medicine.
Michael S. German
Michael S. German is a diabetes researcher and physician-scientist at the University of California, San Francisco, known for showing that serotonin controls beta cell expansion during pregnancy.
Michael S. Lauer
Michael S. Lauer is an American cardiologist and clinical epidemiologist who led NIH extramural research from 2015 to 2025 and studied heart-rate recovery after exercise.
Michael Stümvoll
Michael Stumvoll is a German endocrinologist who directs the Helmholtz Institute for Metabolic, Obesity and Vascular Research in Leipzig and created widely used insulin sensitivity indices.
Michael V. Herman
Michael V. Herman, also known as Michael Herman, is an American cardiologist at the Icahn School of Medicine at Mount Sinai, known for work on ventricular asynergy.
Michele Solimena
Michele Solimena is an Italian-born physician-scientist in diabetology, Professor of Molecular Diabetology at TU Dresden and Director of the Institute for Pancreatic Islet Research, known for discovering GAD autoantibodies in stiff-man syndrome.
Michelle L. O'Donoghue
Michelle L. O'Donoghue is a cardiologist and clinical trialist at Brigham and Women's Hospital and Harvard Medical School, known for leading TIMI trials of heart disease therapies.
Michiel L. Bots
Michiel L. Bots is a Dutch physician-scientist and clinical epidemiologist at University Medical Center Utrecht, known for carotid intima-media thickness ultrasound as a trial endpoint and co-leading the CONVINCE trial.
Miguel López (Spanish physiologist)
Miguel López is a Spanish physiologist and neuroendocrinology researcher, Full Professor at the Universidade de Santiago de Compostela since 2023, known for work on hypothalamic AMPK and energy balance.
Miguel Ondetti
Miguel Angel Ondetti (1930–2004) was an Argentine-born chemist at Squibb who, with David Cushman, discovered captopril, the first orally active ACE inhibitor, sharing the 1999 Lasker Award.
Mihai Gheorghiade
Mihai Gheorghiade was a cardiologist and professor at Northwestern University Feinberg School of Medicine who chaired international heart failure trials and defined the modern study of acute heart failure and the post-discharge vulnerable phase.
Mikhail Kosiborod
Mikhail N. Kosiborod is an American cardiologist and clinical trialist who led the STEP-HFpEF trials of semaglutide in obesity-related heart failure, contributing to Science's 2023 Breakthrough of the Year.
Milton Packer
Milton Packer (M. Packer) is an American cardiologist and clinical trialist at Baylor University Medical Center in Dallas, known for landmark heart failure trials and the neurohormonal hypothesis.
Minglin Ma
Minglin Ma (马明林) is a professor of biological and environmental engineering at Cornell University whose lab develops islet encapsulation devices for type 1 diabetes and co-founded Persista Bio.
Mintu P. Turakhia
Mintu P. Turakhia, also known as Mintu Turakhia, is an American cardiac electrophysiologist at Stanford University and the VA Palo Alto, known for the 2019 Apple Heart Study.
Mirjam Christ‐Crain
Mirjam Christ-Crain, born 1974, is a Swiss endocrinologist, full professor at the University of Basel, and chief of endocrinology at University Hospital Basel, known for copeptin diagnostics.
Mitchell A. Lazar
Mitchell A. Lazar is an American endocrinologist at the University of Pennsylvania who discovered the fat-cell hormone resistin and the circadian receptor REV-ERBα, and was elected to the National Academy of Sciences in 2017.
Mitchell T. Rabkin
Mitchell T. Rabkin is an American endocrinology and diabetes researcher, trained at Harvard and Massachusetts General Hospital, who led Boston's Beth Israel Hospital for three decades from 1966.
Mone Zaidi
Mone Zaidi is a physician-scientist in endocrinology and bone biology at Mount Sinai in New York, known for showing that the pituitary hormone FSH regulates bone mass.
Morris Brown
Morris J. Brown, born 1951, is a British clinical pharmacologist and endocrinologist, Professor of Endocrine Hypertension at Queen Mary University of London, known for work on primary aldosteronism.
Morris J. Birnbaum
Morris J. Birnbaum is an American physician-scientist in diabetes research, credited with cloning GLUT4 and defining insulin signaling through Akt, and a Senior Vice President at Pfizer since 2014.
Morris Schambelan
Morris Schambelan is an American endocrinologist and Professor Emeritus at UCSF, based at San Francisco General Hospital, known for hyporeninemic hypoaldosteronism and HIV wasting research.
Moshe Phillip
Moshe Phillip (Hebrew: משה פיליפ) is an Israeli pediatric endocrinologist who has directed the National Center for Childhood Diabetes at Schneider Children's Medical Center, Petah Tikva, since 1997.
Muredach P. Reilly
Muredach P. Reilly is an Irish-trained cardiologist and physician-scientist at Columbia University, recruited from Penn in 2016, known for identifying the ADAMTS7 gene locus for coronary atherosclerosis.
Murray A. Mittleman
Murray A. Mittleman is a physician and cardiovascular epidemiologist, professor at the Harvard T.H. Chan School of Public Health and co-developer of the case-crossover study design.
Murray Esler
Murray D. Esler is an Australian cardiovascular neuroscientist and Senior Director of the Baker Heart and Diabetes Institute in Melbourne, known for developing norepinephrine spillover methodology.
Murray Korc
Murray Korc is an American endocrinologist and pancreatic cancer researcher known for defining the role of growth factors and their receptors, especially EGFR, in pancreatic cancer.
Muthiah Vaduganathan
Muthiah Vaduganathan is a cardiologist and clinical trialist at Brigham and Women's Hospital and Harvard Medical School, known for quantifying how drug combinations change heart failure outcomes.